ライフサイエンスコーパス: Neisseria

1 The mucosa is colonized with commensal Neisseria.

2 hesis (FabI) as a therapeutic target against Neisseria.

3 l tract incurs a fitness cost for pathogenic Neisseria.

4 studies in the characterization of the genus Neisseria.

5 mmensal-derived DNA by pathogenic strains of Neisseria.

6 reptococcus (18.4%), Haemophilus (12.7%) and Neisseria (6.8%).

7 nhibition of fatty acid synthesis in growing Neisseria, a delayed inhibition of growth phenotype, and

8 ecylammonium bromide in combination with the Neisseria adhesin A variant 3 subunit antigen.

9 B OMV component plus 3 recombinant antigens (Neisseria adhesin A, factor H binding protein [fHbp]-GNA

10 ][G-4], Pseudoramibacter, Streptococcus, and Neisseria and fewer in Actinomyces, Selenomonas, Veillon

11 rly in life, followed by later enrichment of Neisseria and Prevotella spp.

12 found that depletion of the commensal genus Neisseria and the species Streptococcus pneumoniae was a

13 rns of diversity for the genera Escherichia, Neisseria, and Borrelia are generally indistinguishable

14 Across the study group, Rothia, Neisseria, and Haemophilus spp. were associated with goo

15 Neisseria animaloris is considered to be a commensal of

16 Collectively, we propose that commensal Neisseria antagonizes Ngo infection through a DNA-mediat

17 those dominated by Haemophilus, Moraxella or Neisseria associated with enhanced pathogenesis in vitro

18 tered bacterial abundance profile, with more Neisseria, Bacteroides, and Rothia species and less Sphi

19 The solved structures of Neisseria BamD and BamE share overall folds with Escheri

20 a chemical biology tool to determine whether Neisseria can bypass the inhibition of fatty acid synthe

21 Here, we show that the commensal species Neisseria cinerea expresses functional fHbp on its surfa

22 t among non-meningococcal flora, most likely Neisseria commensals.

23 Why the pathogenic Neisseria continue to mediate host damage after thousand

24 The commensal Neisseria do not normally cause pathology, while the two

25 Consistent with these findings, commensal Neisseria elongata accelerates Ngo clearance from the mo

26 Neisseria encodes a functional FabI that was potently in

27 fatty acid labeling experiments showed that Neisseria encodes the ability to incorporate exogenous f

28 Rothia mucilaginosa trending to increase and Neisseria flavescens (P < 0.01) increased after nitrate

29 uely enriched in members of the Haemophilus, Neisseria, Fusobacterium, and Porphyromonas species and

30 in the upper GI tract (Gemella, Veillonella, Neisseria, Fusobacterium, Streptococcus, Prevotella, Pse

31 Streptococcus genus probe 4 and Neisseria genus probe 2 were the most frequently detecte

32 itulated in EPs from the divergent pathogens Neisseria gonorrheae and Escherichia coli Our results su

33 -negative species Neisseria meningitidis and Neisseria gonorrheae and improved activity against the G

34 y loss of capsule and gene conversion of the Neisseria gonorrheae norB-aniA cassette promoting anaero

35 With the examples of Escherichia coli and Neisseria gonorrheae, we present an electrochemical bios

36 -of-care tests for Chlamydia trachomatis and Neisseria gonorrhoea (nucleic acid amplification tests).

37 Neisseria gonorrhoeae (adjusted odds ratio [AOR], 1.75;

38 a rates are rising, and antibiotic-resistant Neisseria gonorrhoeae (AR-Ng) is an urgent public health

39 men who have receptive anal intercourse for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT

40 rectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infections in women.

41 r Chlamydia trachomatis (C. trachomatis) and Neisseria gonorrhoeae (N. gonorrhoeae) infections.

42 accurately identify those with extragenital Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT

43 Urogenital testing misses extragenital Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT

44 lines recommend the systematic screening for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT

45 Neisseria gonorrhoeae (NG) infections are a global healt

46 antibiotic susceptibility testing (AST) for Neisseria gonorrhoeae (Ng) is critically needed to count

47 ous detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and an internal control in t

48 h a network-based mathematical model of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (C

49 are sites of infection for the STD pathogen Neisseria gonorrhoeae (Ngo).

50 cillus crispatus, Gardnerella vaginalis, and Neisseria gonorrhoeae All vaginal microbiota and N. gono

51 Pharyngeal and rectal Neisseria gonorrhoeae and Chlamydia trachomatis play imp

52 Neisseria gonorrhoeae and Neisseria meningitidis are clo

53 irth outcome (OR, 0.24; 95% 0.09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 9

54 pic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are recognized microbial causes.

55 Chlamydia trachomatis and Neisseria gonorrhoeae are the two most common causes of

56 The primary outcome was clearance of Neisseria gonorrhoeae at all initially infected sites, d

57 Neisseria gonorrhoeae bacteria are acknowledged as an ur

58 Microbe, Muenzner and Hauck (2020) find that Neisseria gonorrhoeae blocks exfoliation by producing ni

59 Infrequently, Neisseria gonorrhoeae can cause disseminated gonococcal

60 The obligate human pathogen Neisseria gonorrhoeae carries one of the highest loads o

61 Chlamydia trachomatis and Neisseria gonorrhoeae cases reached a record high in the

62 The bacterium Neisseria gonorrhoeae causes the sexually transmitted in

63 Neisseria gonorrhoeae culture is necessary to determine

64 Neisseria gonorrhoeae cultures were obtained at baseline

65 we performed a meta-analysis of seven large Neisseria gonorrhoeae datasets, as well as Klebsiella pn

66 Neisseria gonorrhoeae deploys a unique immune evasion st

67 if Nanopore sequencing can detect sufficient Neisseria gonorrhoeae DNA to reconstruct whole genomes d

68 The human-restricted pathogen Neisseria gonorrhoeae encodes a single N-acetylmuramyl-l

69 in female mice to study mechanisms by which Neisseria gonorrhoeae evades host-derived antimicrobial

70 Gentamicin alone failed to eradicate Neisseria gonorrhoeae from the pharynx.

71 ased potency and showed its efficacy against Neisseria gonorrhoeae in a mouse vaginal infection model

72 -sensitive and cefixime-resistant strains of Neisseria gonorrhoeae in MSM in England, which was appli

73 n is associated with bacterial burden during Neisseria gonorrhoeae infection and alters the infection

74 point-of-care Gram stain testing to diagnose Neisseria gonorrhoeae infection and nongonococcal urethr

75 he main consequences of sexually transmitted Neisseria gonorrhoeae infection and probably involve an

76 Treatment of Neisseria gonorrhoeae infection is empirical and based o

77 The majority of oropharyngeal Neisseria gonorrhoeae infections are asymptomatic, and m

78 Most oropharyngeal Neisseria gonorrhoeae infections are asymptomatic, and m

79 acid amplification tests (NAATs) to diagnose Neisseria gonorrhoeae infections complicates the perform

80 Multidrug-resistant Neisseria gonorrhoeae is a global health problem.

81 Antimicrobial resistance in Neisseria gonorrhoeae is a major issue of public health,

82 , understanding the evolutionary dynamics of Neisseria gonorrhoeae is a significant public and global

83 The rise of antimicrobial-resistant Neisseria gonorrhoeae is a significant public health con

84 Multidrug-resistant Neisseria gonorrhoeae is a top threat to public health.

85 Neisseria gonorrhoeae is an urgent public health threat

86 ce and spread of antimicrobial resistance in Neisseria gonorrhoeae is globally recognised.

87 The sexually transmitted pathogen Neisseria gonorrhoeae is regarded as being on the way to

88 chanisms of colonization and pathogenesis of Neisseria gonorrhoeae is required to aid development of

89 In the United States, 19.2% of Neisseria gonorrhoeae isolates are resistant to ciproflo

90 Rising azithromycin nonsusceptibility among Neisseria gonorrhoeae isolates threatens current treatme

91 We identified a cluster of Neisseria gonorrhoeae isolates with high-level azithromy

92 Neisseria gonorrhoeae may have contributed to complicati

93 Several Neisseria gonorrhoeae nucleic acid amplification tests (

94 rmed by laboratory isolation or detection of Neisseria gonorrhoeae only from a clinical specimen, and

95 ontal gene transfer between bacteria, and in Neisseria gonorrhoeae plasmids can mediate high-level an

96 The T4SS from Neisseria gonorrhoeae possesses the unique ability to me

97 BD ProbeTec Chlamydia trachomatis Q(x) (CTQ)/Neisseria gonorrhoeae Q(x) (GCQ), Hologic Aptima Combo 2

98 on MIC QC range for zoliflodacin against the Neisseria gonorrhoeae QC strain ATCC 49226 was defined a

99 Neisseria gonorrhoeae releases peptidoglycan fragments d

100 Neisseria gonorrhoeae represents an urgent public health

101 Increasing Neisseria gonorrhoeae resistance to ceftriaxone, the las

102 During infection, Neisseria gonorrhoeae senses and responds to stress; suc

103 Previous studies have demonstrated that Neisseria gonorrhoeae sialylates the terminal N-acetylla

104 etect Chlamydia trachomatis AC2 also detects Neisseria gonorrhoeae Storage and temperature conditions

105 All Neisseria gonorrhoeae strains whose DNA sequences have b

106 hea is expected to rise due to the spread of Neisseria gonorrhoeae strains with decreased susceptibil

107 Neisseria gonorrhoeae successfully overcomes host strate

108 e A (gyrA) genotypic assay for prediction of Neisseria gonorrhoeae susceptibility to ciprofloxacin.

109 5 different antibiotics in 1,102 isolates of Neisseria gonorrhoeae that were confirmed in a second da

110 against multidrug-resistant bacteria such as Neisseria gonorrhoeae The first structure of BamA, the c

111 reasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment.

112 fferent populations in the susceptibility of Neisseria gonorrhoeae to antimicrobials, and the reasons

113 Resistance of Neisseria gonorrhoeae to extended-spectrum cephalosporin

114 rapid AST platform using RNA signatures for Neisseria gonorrhoeae Transcriptome sequencing (RNA-seq)

115 I (HepI) of the lipooligosaccharide (LOS) of Neisseria gonorrhoeae undergoes positive selection durin

116 lamydia trachomatis was detected in 8.7% and Neisseria gonorrhoeae was detected in 6.6%.

117 on antimicrobial resistance determinants in Neisseria gonorrhoeae was developed and is publicly acce

118 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae was established in a multisite, pr

119 he force-dependent velocity of DNA uptake by Neisseria gonorrhoeae We found that the DNA uptake veloc

120 Independent risk factors for oropharyngeal Neisseria gonorrhoeae were assessed among MSM routinely

121 d persons infected with antibiotic-resistant Neisseria gonorrhoeae).

122 resistance and diagnostic escape variants in Neisseria gonorrhoeae, a pathogen associated with a high

123 on effect on incident Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium infecti

124 fluoroquinolone-resistant Campylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were include

125 Positivity rates for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA, de

126 e urine specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis via com

127 d method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no commercial tests are clear

128 has been used to investigate transmission of Neisseria gonorrhoeae, but to date, most studies have no

129 ria species two, Neisseria meningitidis, and Neisseria gonorrhoeae, cause invasive disease: the other

130 NGU was considered idiopathic when Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma

131 mophilus influenzae, Neisseria meningitidis, Neisseria gonorrhoeae, Helicobacter pylori, Moraxella ca

132 Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, is a globally prevalent sexually

133 ng the concurrence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Tricho

134 In Neisseria gonorrhoeae, one of the first bacteria for whi

135 also more prevalent among HIV-infected MSM (Neisseria gonorrhoeae, P = .03; Mycoplasma genitalium, P

136 thogenic species, Neisseria meningitidis and Neisseria gonorrhoeae, straddle the border between comme

137 , Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Streptococcus agalactiae, Chlamyd

138 Neisseria gonorrhoeae, the causative agent of gonorrhea,

139 Neisseria gonorrhoeae, the causative agent of gonorrhea,

140 Neisseria gonorrhoeae, the causative agent of the sexual

141 nce to azithromycin complicates treatment of Neisseria gonorrhoeae, the etiologic agent of gonorrhea.

142 parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mechanisms by which this path

143 Neisseria gonorrhoeae, the sole causative agent of gonor

144 Salmonella enterica, Haemophilus ducreyi and Neisseria gonorrhoeae, together with BamA's homolog, Tam

145 ed for M. genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma

146 hape and dynamics of microcolonies formed by Neisseria gonorrhoeae.

147 pathogenesis of the closely related species, Neisseria gonorrhoeae.

148 ion and stable expression amongst strains of Neisseria gonorrhoeae.

149 he more common sexually transmitted pathogen Neisseria gonorrhoeae.

150 terial infections: Chlamydia trachomatis and Neisseria gonorrhoeae.

151 indistinguishable from infections caused by Neisseria gonorrhoeae.

152 llows it to modulate biofilm accumulation by Neisseria gonorrhoeae.

153 ce and global spread of antibiotic-resistant Neisseria gonorrhoeae.

154 ortant source of antimicrobial resistance in Neisseria gonorrhoeae.

155 arbon source for bacterial pathogens such as Neisseria gonorrhoeae.

156 is active against an important eye pathogen, Neisseria gonorrhoeae.

157 stance for both Streptococcus pneumoniae and Neisseria gonorrhoeae.

158 ide KFF- NgH1 to target the same enzyme from Neisseria gonorrhoeae.

159 a was dominated by Haemophilus, Moraxella or Neisseria (HMN) were at 1.5 times higher risk of CLD tha

160 Here, investigations of the genus Neisseria illustrated the gene-by-gene conceptual approa

161 the immune system to respond effectively to Neisseria infections.

162 Neisseria is a Gram-negative pathogen with phospholipids

163 Whole genome sequences from 181 Neisseria isolates were examined, including those of thr

164 Here, we report that commensal species of Neisseria kill Ngo through a mechanism based on genetic

165 ge for Neisseria meningitidis (P < 0.05) and Neisseria lactamica (P < 0.002) (2-sided Fisher's exact

166 observed in four individuals cocolonized by Neisseria lactamica and Neisseria meningitidis One HGT e

167 did observe an influx of oral taxa, such as Neisseria lactamica, Streptococcus, Prevotella nanceiens

168 ic relatives, we hypothesized that commensal Neisseria may negatively affect Ngo colonization.

169 FA) class II-IV disease, vaccination against Neisseria meningitides, and previous treatment with at l

170 Overall, S. pneumoniae (53.4%), Neisseria meningitidis (13.7%), and Haemophilus influenz

171 ]), Haemophilus influenzae (18 [14.3%]), and Neisseria meningitidis (15 [11.9%]).

172 ed cases of meningitis, 5590 were confirmed: Neisseria meningitidis ([Nm] 85%), Streptococcus pneumon

173 as oropharyngeal carriage of disease-causing Neisseria meningitidis (group A, B, C, W, X, or Y) in st

174 outbreaks, largely attributed to serogroup A Neisseria meningitidis (MenA).

175 (pneumococcus), Haemophilus influenzae, and Neisseria meningitidis (meningococcus) was performed by

176 Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus

177 ing Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus

178 of Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus

179 (pneumococcus), Haemophilus influenzae, and Neisseria meningitidis (meningococcus).

180 Neisseria meningitidis (N. meningitidis), Streptococcus

181 Neisseria meningitidis (Nm) clonal complex 11 (cc11) lin

182 Neisseria meningitidis (Nm) is a Gram-negative diplococc

183 Neisseria meningitidis (Nm) is a nasopharyngeal commensa

184 Neisseria meningitidis (Nm) strains infecting these pati

185 Clusters of Neisseria meningitidis (Nm) urethritis among primarily h

186 meningitis pathogens, 16 (73%) of which were Neisseria meningitidis (Nm).

187 Carriage for Neisseria meningitidis (P < 0.05) and Neisseria lactamic

188 le dynamic regulation mechanism observed for Neisseria meningitidis 3-deoxy-d-arabino-heptulosonate 7

189 Neisseria meningitidis A epidemics have been eliminated

190 of human umbilical vein endothelial cells or Neisseria meningitidis after incubation with human serum

191 Many gram-negative pathogens such as Neisseria meningitidis and Escherichia coli express acid

192 eficiency and compares it to studies done on Neisseria meningitidis and Moraxella catarrhalis; the tw

193 t activity against the Gram-negative species Neisseria meningitidis and Neisseria gonorrheae and impr

194 pathology, while the two pathogenic species, Neisseria meningitidis and Neisseria gonorrhoeae, stradd

195 Neisseria meningitidis and S. pneumoniae remain importan

196 Neisseria gonorrhoeae and Neisseria meningitidis are closely-related bacteria that

197 methods for detecting pharyngeal carriage of Neisseria meningitidis are complex.

198 esent in numerous bacterial pathogens, using Neisseria meningitidis as a model organism.

199 dentified as a ligand for these molecules on Neisseria meningitidis As with N. meningitidis NspA (Nm-

200 es of the substrate-bound ClpXP complex from Neisseria meningitidis at 2.3 to 3.3 angstrom resolution

201 Administration to respond to an outbreak of Neisseria meningitidis B at a U.S. university.

202 Neisseria meningitidis can be transmitted via asymptomat

203 , and AcrIIC3 proteins were found to inhibit Neisseria meningitidis Cas9 (NmeCas9) activity in bacter

204 Neisseria meningitidis causes bacterial meningitis and s

205 The bacterium Neisseria meningitidis causes life-threatening meningiti

206 e (SPR) based biosensor for the detection of Neisseria meningitidis DNA employing Kretschmann configu

207 nd impairs the fitness of the human pathogen Neisseria meningitidis during infection.

208 ningococcal disease (IMD) due to serogroup Y Neisseria meningitidis emerged in Europe during the 2000

209 antibodies raised against sheaths presenting Neisseria meningitidis factor H binding protein (fHbp) a

210 s 3 main recombinant proteins, including the Neisseria meningitidis factor H binding protein (fHbp),

211 ta that the class III Fic protein NmFic from Neisseria meningitidis gets autoadenylylated in cis, the

212 H binding protein (fHbp) is a lipoprotein of Neisseria meningitidis important for the survival of the

213 specific protection against capsular group B Neisseria meningitidis infections, but the full breadth

214 Neisseria meningitidis is a commensal microbe that colon

215 Neisseria meningitidis is a frequent colonizer of the hu

216 Neisseria meningitidis is a human commensal that can als

217 Neisseria meningitidis is a human-specific bacterium tha

218 Neisseria meningitidis is a leading cause of bacterial m

219 Neisseria meningitidis is a major cause of bacterial men

220 Neisseria meningitidis is an obligate human commensal ba

221 Although Neisseria meningitidis is naturally competent and porB g

222 Neisseria meningitidis is one of the few commensal bacte

223 duals cocolonized by Neisseria lactamica and Neisseria meningitidis One HGT event resulted in the acq

224 Asymptomatic oropharyngeal carriage of Neisseria meningitidis peaks in adolescence and young ad

225 he availability of antibiotics and vaccines, Neisseria meningitidis remains a major cause of meningit

226 ing in 2010, the burden of meningitis due to Neisseria meningitidis serogroup A (NmA) has substantial

227 To combat Neisseria meningitidis serogroup A epidemics in the meni

228 ecially in the African meningitis belt where Neisseria meningitidis serogroup A historically caused l

229 the countries of the meningitis belt, where Neisseria meningitidis serogroup A historically caused l

230 Vaccination campaign against Neisseria meningitidis serogroup A was carried out in 20

231 rrelate of protection against infection with Neisseria meningitidis serogroup A, we use an assumed SB

232 Neisseria meningitidis serogroup B (MnB) is a leading ca

233 Neisseria meningitidis serogroup C (NmC) was responsible

234 Acetylated sialic acid has been found in the Neisseria meningitidis serogroup W (NmW) capsular polysa

235 July 2016, Togo experienced its first major Neisseria meningitidis serogroup W (NmW) outbreak.

236 he United Kingdom due to a sublineage of the Neisseria meningitidis serogroup W ST-11 clonal complex

237 des of recombinant capsular polymerases from Neisseria meningitidis serogroups A (CsaB) and X (CsxA)

238 Neisseria meningitidis serogroups A and X are among the

239 ve meningococcal disease is mainly caused by Neisseria meningitidis serogroups A, B, C, X, W, and Y.

240 age prevention against antigenically diverse Neisseria meningitidis strains and to compare this prote

241 erized a TE6 thioesterase from the bacterium Neisseria meningitidis Structural analysis with X-ray cr

242 Neisseria meningitidis use Type IV pili (T4P) to adhere

243 tor H binding protein (FHbp) is an important Neisseria meningitidis virulence factor that binds a neg

244 NmLgtB-B beta1-4 galactosyltransferase from Neisseria meningitidis we demonstrate fast and robust ac

245 egative pathogens Haemophilus influenzae and Neisseria meningitidis We hypothesized that activation o

246 ve isolates and 25 isolates from carriers of Neisseria meningitidis without disease.

247 Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus accounted for 66

248 ry-confirmed Streptococcus pneumoniae (Spn), Neisseria meningitidis, and Haemophilus influenzae menin

249 igen) and qPCR for Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.

250 ten human-restricted Neisseria species two, Neisseria meningitidis, and Neisseria gonorrhoeae, cause

251 h intact, heat-killed cells of Gram-negative Neisseria meningitidis, capsular serogroup C (MenC) or G

252 lipid A phosphoethanolamine transferase from Neisseria meningitidis, determined to 2.75-A resolution.

253 eillance targeted meningitis cases caused by Neisseria meningitidis, Haemophilus influenzae, and Stre

254 terial meningitis, which is caused mainly by Neisseria meningitidis, Haemophilus influenzae, and Stre

255 tococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, Mycoplasma pneumoniae, Mycobacte

256 ajor human pathogens Haemophilus influenzae, Neisseria meningitidis, Neisseria gonorrhoeae, Helicobac

257 rs of bacterial pathogenic strains including Neisseria meningitidis, Pseudomonas aeruginosa and Esche

258 uman pathogens, Streptococcus pneumoniae and Neisseria meningitidis, revealed both previously identif

259 Neisseria meningitidis, Streptococcus pneumoniae, or Hae

260 mophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus pneumoniae, Strept

261 ccus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, the 3 most common bacteria causi

262 Neisseria meningitidis, typically a resident of the oro-

263 Gram-negative bacterial pathogens including Neisseria meningitidis, Vibrio cholerae, and Salmonella

264 Hyperinvasive lineages of Neisseria meningitidis, which persist despite extensive

265 ere we expressed the gene encoding LpxA from Neisseria meningitidis, which specifically attaches 3OH-

266 ed Cas9s to identify a compact ortholog from Neisseria meningitidis-Nme2Cas9-that recognizes a simple

267 the porin PorB from the pathogenic bacterium Neisseria meningitidis.

268 rial pathogens including Vibrio cholerae and Neisseria meningitidis.

269 ation rates with Streptococcus pneumoniae or Neisseria meningitidis.

270 ecifically inhibit the CRISPR-Cas9 system of Neisseria meningitidis.

271 orms of ClpP from the Gram-negative pathogen Neisseria meningitidis.

272 dent responses except that made with group C Neisseria meningitidis; in the latter case, only peptide

273 The outer membrane protein (OMP) from Neisseria meninigitidis, PorB, is a naturally occurring

274 al and gonococcal disease, and mechanisms of Neisseria pathogenicity.

275 pecies (N. meningitidis; N. gonorrhoeae; and Neisseria polysaccharea) and genomes of isolates unassig

276 australis, and Alloprevotella, Leptotrichia, Neisseria, Porphyromonas, and Prevotella.

277 The 10 human-restricted Neisseria species all colonize mucosal surfaces, but sho

278 le genomes has indicated that some commensal Neisseria species also contain genes that potentially en

279 ial susceptibility in NG, we categorized the Neisseria species and compared mean MIC levels between d

280 outer membrane protein that is common among Neisseria species and is required for survival.

281 Many hypothesize that commensal Neisseria species are an important reservoir for genetic

282 ity foregut community with a highly abundant Neisseria species associated with foregut lactate.

283 At least 1 commensal Neisseria species colonized all men.

284 lore this question, we focused on pathogenic Neisseria species harboring a genomic island in their di

285 the past month was strongly associated with Neisseria species having increased MICs to cefixime, cef

286 h participant (range, 1-4) with 10 different Neisseria species identified overall.

287 Of the ten human-restricted Neisseria species two, Neisseria meningitidis, and Neiss

288 A median of 1 Neisseria species was cultured from each participant (ra

289 Seven putative novel Neisseria species were identified, confirming the import

290 f the LT, an outer membrane lipoprotein from Neisseria species with a disordered active site helix (a

291 any antibiotics may select for oropharyngeal Neisseria species with antimicrobial resistance.

292 We collected pharyngeal specimens, cultured Neisseria species, and measured minimum inhibitory conce

293 12 taxa associated with gum health including Neisseria spp. and a significant decrease in 10 taxa ass

294 ken (n = 112) to ascertain the prevalence of Neisseria spp. following the eighth case of invasive men

295 at provide insight into the evolution of the Neisseria, the epidemiology of meningococcal and gonococ

296 noculum in which Streptococcus, Haemophilus, Neisseria, Veillonella and Prevotella species predominat

297 a concentrative nucleoside transporter from Neisseria wadsworthii.

298 252 remained an effective antibacterial when Neisseria were supplemented with exogenous fatty acids.

299 bacter, Corynebacterium, Actinobacteria, and Neisseria were the signature taxa of C environment-assoc

300 The proportion of Neisseria with reduced susceptibility to ciprofloxacin w